Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Identification of an MLL4-GPS2 fusion as an oncogenic driver of undifferentiated spindle cell sarcoma in a child

Title: Identification of an MLL4-GPS2 fusion as an oncogenic driver of undifferentiated spindle cell sarcoma in a child
Authors: O'Meara, Elaine; Stack, Deirdre; Phelan, Susan; McDonagh, Naomi; Kelly, Lorna; Sciot, Raf; Debiec-Rychter, Maria; Morris, Thomas; Cochrane, Doug; Sorensen, Poul; O'Sullivan, Maureen J.
Source: ISSN:1045-2257 ; ISSN:1098-2264 ; Genes, Chromosomes & Cancer, vol. 53 (12), (991-8.
Publisher Information: Wiley-Liss, Inc.
Publication Year: 2014
Subject Terms: Science & Technology; Life Sciences & Biomedicine; Oncology; Genetics & Heredity; Health Research Board of Ireland (CSA; 13); National Children's Research Centre; HUMAN HEPATOCELLULAR-CARCINOMA; B-VIRUS DNA; H3K79 METHYLATION; GENE; LEUKEMIA; REARRANGEMENTS; APOPTOSIS; HOMOLOG; MLL2; Health Research Board of Ireland (CSA/2012/13); Adult; Aged; 80 and over; Animals; Brain Neoplasms; Child; Chromosomes; Human; Pair 17; Pair 19; Cohort Studies; DNA-Binding Proteins
Time: 2012
Description: Undifferentiated spindle cell sarcoma (UDS) is a poorly defined or understood entity, essentially a waste-basket for cases failing to fulfill criteria for better-established diagnoses based on combined histology, immunohistochemistry, and tumor genetic assays. We identified a novel chromosomal translocation t(17;19)(p13;q13) in a pediatric UDS and have characterized this alteration to show rearrangement of the MLL4 and GPS2 genes, resulting in an in-frame fusion gene MLL4-GPS2, the expression of which promotes anchorage-independent growth. MLL4 was previously reported to be similarly rearranged in hepatocellular carcinomas, notably those positive for hepatitis B virus. Isolated reports of individual rearrangements of GPS2 in a prostate carcinoma cell line and in glioblastoma multiforme, each with different partner genes, recently emerged from high-throughput sequencing studies but have not been further evaluated for biological effect. © 2014 Wiley Periodicals, Inc. ; sponsorship: Supported by the Health Research Board of Ireland Clinician Scientist Award (CSA/2012/13) granted to MJO'S. (Health Research Board of Ireland Clinician Scientist Award|CSA/2012/13, Health Research Board (HRB)|CSA-2012-13) ; status: Published
Document Type: article in journal/newspaper
Language: English
Relation: https://lirias.kuleuven.be/handle/123456789/460066; https://doi.org/10.1002/gcc.22208; https://pubmed.ncbi.nlm.nih.gov/25139254
DOI: 10.1002/gcc.22208
Availability: https://lirias.kuleuven.be/handle/123456789/460066; https://doi.org/10.1002/gcc.22208; https://pubmed.ncbi.nlm.nih.gov/25139254
Rights: info:eu-repo/semantics/restrictedAccess ; intranet
Accession Number: edsbas.185AF274
Database: BASE